Clinical trial

Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer

NCT00897143

Study summary

ClinicalTrials.gov

Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer

Design: OBSERVATIONAL · Status: WITHDRAWN · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

GENETIC · Unmapped registry intervention microarray analysis Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention mutation analysis Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention flow cytometry Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention immunologic technique Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeOBSERVATIONAL

Start date2007-06-01

PhaseN/A

Conditions

Lung Cancerverified · MONDO: lung cancer

Metastatic Cancerverified · MONDO: metastatic malignant neoplasm

Interventions

microarray analysisGENETIC

mutation analysisGENETIC

flow cytometryOTHER

immunologic techniqueOTHER

Sponsors & collaborators

Case Comprehensive Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

ClevelandOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00897143 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.